MedPath

CROWN LABORATORIES, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

4

Active:0
Completed:4

Trial Phases

2 Phases

Phase 2:1
Not Applicable:3

Drug Approvals

12

FDA:12

Drug Approvals

Blue Lizard Sensitive SPF 50 Sunscreen

Approval Date
May 20, 2025
FDA

Blue Lizard Baby SPF 50 Sunscreen

Approval Date
May 20, 2025
FDA

Blue Lizard SPF 15 Lip Balm

Approval Date
May 14, 2025
FDA

Desenex Antifungal Foot Cream

Approval Date
Mar 24, 2025
FDA

Blue Lizard Sheer Face SPF 50 Sunscreen

Approval Date
Mar 20, 2025
FDA

Blue Lizard Kids SPF 50 Sunscreen

Approval Date
Mar 3, 2025
FDA

Blue Lizard Sport SPF 50 Sunscreen

Approval Date
Feb 28, 2025
FDA

Nystatin Cream

Approval Date
Oct 24, 2023
FDA

Hydrocortisone

Approval Date
Oct 24, 2023
FDA

TRIDERM

Approval Date
Oct 24, 2023
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (75.0%)
Phase 2
1 (25.0%)

A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Microneedling With SkinPen in Female and Male Subjects With Facial Acne Vulgaris, Ages 18 Through 45

Not Applicable
Completed
Conditions
Acne Vulgaris
First Posted Date
2021-10-08
Last Posted Date
2022-03-28
Lead Sponsor
Crown Laboratories, Inc.
Target Recruit Count
31
Registration Number
NCT05071274
Locations
🇺🇸

Crown Laboratories, Dallas, Texas, United States

A Study to Evaluate the Efficacy of Microneedling as a Stand-alone Treatment for Vitiligo

Not Applicable
Completed
Conditions
Vitiligo
First Posted Date
2021-09-22
Last Posted Date
2023-05-24
Lead Sponsor
Crown Laboratories, Inc.
Target Recruit Count
13
Registration Number
NCT05053022
Locations
🇺🇸

Crown Laboratories, Dallas, Texas, United States

A Proof of Concept Study to Evaluate the Efficacy and Tolerability of Skinpen on Male and Female Subjects' Dorsal Hands as a Treatment of Hand Aging

Not Applicable
Completed
Conditions
Skin Aging
First Posted Date
2021-09-01
Last Posted Date
2023-12-18
Lead Sponsor
Crown Laboratories, Inc.
Target Recruit Count
18
Registration Number
NCT05030051
Locations
🇺🇸

Crown Laboratories, Dallas, Texas, United States

A Six Week Topical Cream Study for Subjects With Ichthyosis Vulgaris

Phase 2
Completed
Conditions
Ichthyosis Vulgaris
Interventions
Drug: 146-9251 cream
Drug: Vehicle cream
First Posted Date
2017-06-02
Last Posted Date
2021-08-10
Lead Sponsor
Crown Laboratories, Inc.
Target Recruit Count
80
Registration Number
NCT03173547
Locations
🇺🇸

Crown investigative site 01, San Diego, California, United States

🇺🇸

Crown Investigative site 07, Plainfield, Indiana, United States

🇺🇸

Crown Investigative site 08, Metairie, Louisiana, United States

and more 4 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.